Read more at CNBC.
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
Date: |
Sort by
Filter
Date
Items per page
-
Eli Lilly falls on a rival's obesity study — plus, we're removing 3 stocks from our watchlist
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.CNBC - Business -
Roche says weight loss drug shows promising results in early trial
The weekly injection helped patients with obesity lose 18.8% of their weight relative to those who received a placebo, after 24 weeks in the phase one trial.CNBC - Business -
Roche Climbs After Weight-Loss Drug Shows Efficacy
Roche Holding said its weight-loss drug candidate achieved positive results in an early-stage trial, giving the company a boost in its bid to catch up to Novo Nordisk and Eli Lilly in a class of medicines that has shaken up everything from pharma ...The Wall Street Journal - Business -
FDA Approves Amgen Drug for Persistently Deadly Form of Lung Cancer
The treatment is for patients with small cell lung cancer, which afflicts about 35,000 people in the U.S. a year.The New York Times - Science - FDA -
Denmark Raises Growth Forecast as Novo Expands Output
Yahoo News - World -
Israel's Eurovision team accuse rivals of 'hatred'
Its national broadcaster says it faced hostility simply because "we are Israelis and we were there".BBC News - Top stories - Israel -
Verstappen fears rivals have made step forward
Max Verstappen said Red Bull has work to do to maintain its big advantage over the rest of the field after a tough day of practice ahead of the Emilia-Romagna Grand Prix.ESPN - Sports -
Swiatek dominates Sabalenka for 'dirt double'
The latest matchup between top-ranked Iga Swiatek and No. 2 Aryna Sabalenka was hardly a contest.ESPN - Sports -
1 in 3 high-profile athletes threatened by bettors
The NCAA reports that nearly one in three star athletes receive abusive messages from people with "betting interests," with some college basketball players getting death threats during championship tournaments.ESPN - Sports -
Wegovy Can Keep Weight Off for at Least 4 Years, Research Shows
Users receiving weekly injections saw their weight fall, plateau, and stabilize over the course of a four-year trial—but it’s still unclear how long these effects last after stopping taking the drug.Wired - Tech
More from CNBC
-
Soaring debt and deficits causing worry about threats to the economy and markets
Government debt that has swelled nearly 50% is capturing increasing worry both on Wall Street and in Washington.CNBC - Business -
Microsoft set to unveil its vision for AI PCs at Build developer conference
Microsoft Build 2024 starts Tuesday, and the company is expected to talk about how Windows will power new "AI PCs."CNBC - Business - Microsoft -
Media giants lean on sports as Hollywood strikes still loom over content slates
Media companies charming advertisers during the Upfront meetings let sports take center stage as content slates still suffer from last year's Hollywood strikes.CNBC - Business -
Some consumers are punting big purchases like pools and mattresses
There are some signs that shoppers are holding off on big-ticket buys, the latest signal of the economy contracting at the hands of tighter monetary policy.CNBC - Business -
Social Security's 'biggest myth' leads people to claim early, expert says. Even a slight delay can boost retirement income
Fears about Social Security's future shouldn't be the primary reason for claiming retirement benefits at 62, experts say.CNBC - Business